US FDA places clinical hold on Tenaya gene therapy trial for rare heart disease
(Reuters) -Tenaya Therapeutics said on Friday the U.S. Food and Drug Administration has placed a clinical hold on its trial of an experimental gene therapy for a type of rare inherited heart disease. Shares of the company slipped more than 20% in extended...
Reuters